|
124 Companies |
|
161 Products |
|
161 Products |
|
116 Mechanisms of Action |
|
11 Trials |
|
2428 News |
|
| «12...3536373839404142434445...4950» |
- Enrollment change: Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV (clinicaltrials.gov) - Oct 25, 2012
P=N/A, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=120 --> 0
- tenofovir disoproxil fumarate / Generic mfg.
Trial completion: Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy (clinicaltrials.gov) - Oct 25, 2012
P=N/A, N=17, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=120 --> 0 Active, not recruiting --> Completed
- Trial completion: Long-term Follow-up of HIV Infected Patients Identified During Early Infection (clinicaltrials.gov) - Oct 25, 2012
P=N/A, N=157, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission (clinicaltrials.gov) - Oct 25, 2012
P=N/A, N=283, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Directly Observed Therapy in HIV Infected Adolescent Focus Groups (clinicaltrials.gov) - Oct 25, 2012
P=N/A, N=30, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ALVAC-HIV / National Institute of Allergy and Infectious Diseases, Sanofi
Trial completion: Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm (clinicaltrials.gov) - Oct 25, 2012
P1, N=18, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Adherence: A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly (clinicaltrials.gov) - Oct 25, 2012
P=N/A, N=1248, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients (clinicaltrials.gov) - Oct 25, 2012
P=N/A, N=460, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Outcomes of Anti-HIV Therapy During Early HIV Infection (clinicaltrials.gov) - Oct 25, 2012
P=N/A, N=48, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Viracept (nelfinavir) / ViiV Healthcare, Roche
Trial completion: A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART (clinicaltrials.gov) - Oct 25, 2012
P=N/A, N=148, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Isentress (raltegravir) / Merck (MSD)
Trial completion: A Pharmacokinetic Study to Evaluate the Effect of Antacids on Raltegravir (MK-0518) in HIV-Infected Participants (MK-0518-247) (clinicaltrials.gov) - Oct 24, 2012
P1, N=27, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Effects of Changing HIV Therapy at Lower Versus Higher Viral Loads (clinicaltrials.gov) - Oct 24, 2012
P2, N=60, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients (clinicaltrials.gov) - Oct 24, 2012
P=N/A, N=150, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV (clinicaltrials.gov) - Oct 24, 2012
P=N/A, N=39, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- lamivudine/zidovudine / Generic mfg.
Trial completion: Zidovudine and Lamivudine Given Once Versus Twice Daily (clinicaltrials.gov) - Oct 24, 2012
P1, N=20, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Viracept (nelfinavir) / ViiV Healthcare, Roche
Trial completion, IO biomarker: Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV (clinicaltrials.gov) - Oct 24, 2012
P=N/A, N=398, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children (clinicaltrials.gov) - Oct 24, 2012
P=N/A, N=100, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Computer-Assisted Tailored Cue-card Health [CATCH] Study (clinicaltrials.gov) - Oct 23, 2012
P1, N=122, Completed, Sponsor: RTI International
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: HIV in Specific Parts of the Body of Patients Who Are Changing or Starting Potent Anti-HIV Drugs (clinicaltrials.gov) - Oct 23, 2012
P=N/A, N=164, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women (clinicaltrials.gov) - Oct 23, 2012
P=N/A, N=160, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Long-Term Effects of HIV Exposure and Infection in Children (clinicaltrials.gov) - Oct 23, 2012
P=N/A, N=4150, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients (clinicaltrials.gov) - Oct 23, 2012
P=N/A, N=50, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies (clinicaltrials.gov) - Oct 23, 2012
P=N/A, N=2000, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- azithromycin / Generic mfg.
Trial completion: Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy (clinicaltrials.gov) - Oct 23, 2012
P=N/A, N=636, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants (clinicaltrials.gov) - Oct 23, 2012
P=N/A, N=2400, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Isentress (raltegravir) / Merck (MSD)
Trial withdrawal: A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells (clinicaltrials.gov) - Oct 22, 2012
P4, N=0, Withdrawn, Sponsor: Community Research Initiative of New England
Active, not recruiting --> Completed Active, not recruiting --> Withdrawn
- Trial termination: Rapid HIV Tests for Women Late in Pregnancy and During Labor (clinicaltrials.gov) - Oct 22, 2012
P=N/A, N=7500, Terminated, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Withdrawn Active, not recruiting --> Terminated
- Isentress (raltegravir) / Merck (MSD)
Enrollment change: A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells (clinicaltrials.gov) - Oct 22, 2012
P4, N=0, Withdrawn, Sponsor: Community Research Initiative of New England
Active, not recruiting --> Terminated N=15 --> 0
- Trial completion: The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort - (clinicaltrials.gov) - Oct 21, 2012
P=N/A, N=326, Completed, Sponsor: Holdsworth House Medical Practice
N=15 --> 0 Recruiting --> Completed
- | Enrollment closed: Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO) (clinicaltrials.gov) - Oct 18, 2012
P3, N=2073, Active, not recruiting, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting --> Completed Recruiting --> Active, not recruiting
- | rifampicin / Generic mfg.
Trial completion: Tuberculosis Prevention for HIV Infected Adults (clinicaltrials.gov) - Oct 18, 2012
P3, N=1148, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Selzentry (maraviroc) / ViiV Healthcare, Isentress (raltegravir) / Merck (MSD)
Trial completion: Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Na (clinicaltrials.gov) - Oct 17, 2012
P2, N=31, Completed, Sponsor: Rockefeller University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| nevirapine / Generic mfg.
Trial completion: A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children. (clinicaltrials.gov) - Oct 16, 2012
P1, N=86, Completed, Sponsor: Boehringer Ingelheim
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Victrelis (boceprevir) / Roche, Merck (MSD)
Trial completion: A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4) (clinicaltrials.gov) - Oct 15, 2012
P2, N=99, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Adherence: Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV (clinicaltrials.gov) - Oct 15, 2012
P=N/A, N=150, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- fluoxetine / Generic mfg.
Trial completion, Adherence: Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy (clinicaltrials.gov) - Oct 15, 2012
P2, N=150, Completed, Sponsor: Massachusetts General Hospital
Recruiting --> Completed Recruiting --> Completed
- | darunavir/ritonavir / Generic mfg., pravastatin / Generic mfg.
Trial completion: Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin (clinicaltrials.gov) - Oct 14, 2012
P4, N=32, Completed, Sponsor: University of Colorado, Denver
Recruiting --> Completed Recruiting --> Completed
- New P1 trial: Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers (clinicaltrials.gov) - Oct 11, 2012
P1, N=64, Active, not recruiting, Sponsor: International AIDS Vaccine Initiative
- || Triumeq (dolutegravir/abacavir/lamivudine) / ViiV Healthcare
Enrollment change: Evaluation of the Bioequivalence of a Combined Formulated Tablet (clinicaltrials.gov) - Oct 10, 2012
P1, N=66, Completed, Sponsor: ViiV Healthcare
Recruiting --> Completed N=52 --> 66
- Vocabria (cabotegravir oral) / ViiV Healthcare
Enrollment change: A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects (clinicaltrials.gov) - Oct 10, 2012
P1, N=28, Completed, Sponsor: ViiV Healthcare
N=52 --> 66 N=56 --> 28
- methamphetamine / Generic mfg.
Enrollment open: Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine Users (clinicaltrials.gov) - Oct 9, 2012
P=N/A, N=450, Recruiting, Sponsor: University of Colorado, Denver
N=56 --> 28 Not yet recruiting --> Recruiting
- ||||| Tybost (cobicistat) / Gilead
Enrollment closed: Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment (clinicaltrials.gov) - Oct 9, 2012
P3, N=100, Active, not recruiting, Sponsor: Gilead Sciences
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- | sodium phenylbutyrate / Generic mfg.
New P2 trial: Immune Reconstitution in HIV Disease (IREHIV) (clinicaltrials.gov) - Oct 8, 2012
P2, N=200, Recruiting, Sponsor: Karolinska Institutet
- Trial completion, IO biomarker: Study on Immunopathogenesis in HIV and Hepatitis C Coinfection (clinicaltrials.gov) - Oct 8, 2012
P=N/A, N=59, Completed, Sponsor: Rush University Medical Center
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Januvia (sitagliptin) / Merck (MSD)
Trial initiation date: Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation (clinicaltrials.gov) - Oct 4, 2012
P3, N=36, Recruiting, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Initiation date: Jul 2012 --> Oct 2012
- Januvia (sitagliptin) / Merck (MSD)
Enrollment open: Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation (clinicaltrials.gov) - Oct 4, 2012
P3, N=36, Recruiting, Sponsor: Washington University School of Medicine
Initiation date: Jul 2012 --> Oct 2012 Not yet recruiting --> Recruiting
- cenicriviroc (TBR-652) / Takeda, AbbVie
Trial termination: Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors (clinicaltrials.gov) - Sep 30, 2012
P2b, N=5, Terminated, Sponsor: University of California, San Francisco
Not yet recruiting --> Recruiting Active, not recruiting --> Terminated; Low enrollment
- methamphetamine / Generic mfg.
Trial initiation date: Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users (clinicaltrials.gov) - Sep 26, 2012
P2, N=429, Completed, Sponsor: University of California, San Diego
Active, not recruiting --> Terminated; Low enrollment Initiation date: Sep 2006 --> Feb 2007
- methamphetamine / Generic mfg.
Trial completion: Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users (clinicaltrials.gov) - Sep 26, 2012
P2, N=429, Completed, Sponsor: University of California, San Diego
Initiation date: Sep 2006 --> Feb 2007 Active, not recruiting --> Completed
- methamphetamine / Generic mfg.
Trial completion: STD Risk Reduction for Heterosexual Methamphetamine Users (clinicaltrials.gov) - Sep 26, 2012
P=N/A, N=432, Completed, Sponsor: University of California, San Diego
Active, not recruiting --> Completed Active, not recruiting --> Completed